NIVALIS THERAPEUTICS INC - COM (NVLS)

CUSIP: 65481J109

Q3 2016 13F Holders as of 30 Sep 2016

Type / Class
Equity / COM
Total 13F shares
12,317,427
Share change
-307,199
Total reported value
$100,138,000
Price per share
$8.13
Number of holders
50
Value change
-$1,826,903
Number of buys
17
Number of sells
18

Quarterly Holders Quick Answers

What is CUSIP 65481J109?
CUSIP 65481J109 identifies NVLS - NIVALIS THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NIVALIS THERAPEUTICS INC - COM (NVLS) as of Q3 2016

As of 30 Sep 2016, NIVALIS THERAPEUTICS INC - COM (NVLS) was held by 50 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 12,317,427 shares. The largest 10 holders included DEERFIELD MANAGEMENT CO, BVF INC/IL, WELLINGTON MANAGEMENT GROUP LLP, AXA, TIGER MANAGEMENT L.L.C., KINGDON CAPITAL MANAGEMENT, L.L.C., FRANKLIN RESOURCES INC, Rock Springs Capital Management LP, JENNISON ASSOCIATES LLC, and VANGUARD GROUP INC. This page lists 50 institutional shareholders reporting positions in this security for the Q3 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.